Connect Biopharma Holdings (CNTB) Operating Expenses (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Operating Expenses of $19.8 million for Q1 2026, up 27.37% sequentially from $15.5 million in Q4 2025, and up 72.76% YoY from $11.4 million in Q1 2025.
Connect Biopharma Holdings (CNTB) Operating Expenses (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Operating Expenses for 3 years, with the latest figure at $19.8 million in Q1 2026.
- Quarterly Operating Expenses rose 72.76% year-over-year to $19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66.5 million (up 40.53% YoY) and the FY2025 annual result came in at $58.1 million, up 19.91% from the prior year.
- Operating Expenses climbed to $19.8 million in Q1 2026 per CNTB's latest filing, from $15.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $19.8 million in Q1 2026 and troughed at $10.3 million in Q4 2024.
- A 3-year average of $14.0 million and a median of $13.5 million in 2025 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses declined 9.39% in 2025, then soared 72.76% in 2026.
- Over 3 years, Operating Expenses stood at $10.3 million in 2024, then surged by 50.49% to $15.5 million in 2025, then rose by 27.37% to $19.8 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $19.8 million, $15.5 million, and $17.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 20.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.37 Mn |
| Mar 31, 2026 | 19.78 Mn |
| Dec 31, 2025 | 15.53 Mn |
| Sep 30, 2025 | 17.69 Mn |
| Jun 30, 2025 | 13.47 Mn |
| Mar 31, 2025 | 11.45 Mn |
| Dec 31, 2024 | 10.32 Mn |
| Sep 30, 2024 | 15.07 Mn |
| Jun 30, 2024 | 10.47 Mn |
| Mar 31, 2024 | 12.63 Mn |